UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025303
Receipt number R000029033
Scientific Title Will silicon urinary catheter prevent Catheter Related Bladder Discomfort after anesthesia? compared with latex urinary catheter for equal urine drainage function.
Date of disclosure of the study information 2016/12/16
Last modified on 2017/07/03 15:05:54

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Will silicon urinary catheter prevent Catheter Related Bladder Discomfort after anesthesia?
compared with latex urinary catheter for equal urine drainage function.

Acronym

Will silicon urinary catheter prevent Catheter Related Bladder Discomfort after anesthesia?
compared with latex urinary catheter for equal urine drainage function.

Scientific Title

Will silicon urinary catheter prevent Catheter Related Bladder Discomfort after anesthesia?
compared with latex urinary catheter for equal urine drainage function.

Scientific Title:Acronym

Will silicon urinary catheter prevent Catheter Related Bladder Discomfort after anesthesia?
compared with latex urinary catheter for equal urine drainage function.

Region

Japan


Condition

Condition

Catheter Related Bladder DIscomfort

Classification by specialty

Urology Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Find out will silicon urinary catheter prevent Catheter Related Bladder Discomfort (CRBD) after anesthesia compared with latex urinary catheter for equal urine drainage function.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Severity of Catheter Related Bladder Discomfort (CRBD)

(before exiting operation room and every 24h till the urinary catheter removed)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Insert silicon urinary catheter after general anesthesia.
Keep inserted as much as needed after operation.

Interventions/Control_2

Insert latex urinary catheter after general anesthesia.
Keep inserted as much as needed after operation.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >=

Gender

Male

Key inclusion criteria

Patient undergoing respiratory surgery, upper abdominal surgery and spinal surgery.

Key exclusion criteria

Bladder outflow obstruction, over activate bladder, diabetes mellitus, Parkinson's disease, Dementia, and chronic opioid use.

Target sample size

66


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akira Ide

Organization

Kimitsu chuuou Hospital

Division name

Department of anesthesia

Zip code


Address

1010, Sakurai, Kisarazu city, Prefecture of Chiba, Japan

TEL

0438-36-1071

Email

simple_style_ak@yahoo.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Akira Ide

Organization

Kimitsu chuuou Hospital

Division name

Department of anesthesia

Zip code


Address

1010, Sakurai, Kisarazu city, Prefecture of Chiba, Japan

TEL

0438-36-1071

Homepage URL


Email

simple_style_ak@yahoo.co.jp


Sponsor or person

Institute

Kimitsu chuuou Hospital

Institute

Department

Personal name



Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 12 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2016 Year 11 Month 24 Day

Date of IRB


Anticipated trial start date

2016 Year 12 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 12 Month 16 Day

Last modified on

2017 Year 07 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029033